SHL Telemedicine Completes Rights Offering and Capital Increase
Ticker: SHMLF · Form: 6-K · Filed: Dec 3, 2025 · CIK: 1166834
| Field | Detail |
|---|---|
| Company | Shl Telemedicine Ltd (SHMLF) |
| Form Type | 6-K |
| Filed Date | Dec 3, 2025 |
| Risk Level | medium |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: capital-raise, rights-offering, press-release
TL;DR
SHL Telemedicine just closed its capital raise, signaling potential growth or financial strengthening.
AI Summary
On December 3, 2025, SHL Telemedicine Ltd. announced the successful completion of its rights offering and capital increase. The company, headquartered at 90 Yigal Alon Street in Tel Aviv, Israel, filed a Form 6-K to report this development.
Why It Matters
This indicates the company has successfully raised additional capital, which could be used for expansion, debt reduction, or operational improvements.
Risk Assessment
Risk Level: medium — Capital raises can be positive but also signal a need for funds, which warrants further investigation into the company's financial health and the terms of the offering.
Key Players & Entities
- SHL Telemedicine Ltd. (company) — Registrant
- December 3, 2025 (date) — Date of press release and filing
- 90 Yigal Alon Street Tel Aviv (location) — Company's principal executive offices
FAQ
What was the total amount of capital raised in the rights offering?
The filing does not specify the total amount of capital raised in the rights offering.
What will the raised capital be used for?
The filing does not detail the specific use of the capital raised.
When was the press release announcing the completion of the rights offering issued?
The press release was issued on December 3, 2025.
What form is SHL Telemedicine Ltd. filing with the SEC?
SHL Telemedicine Ltd. is filing a Form 6-K.
Does SHL Telemedicine Ltd. file annual reports under Form 20-F?
Yes, SHL Telemedicine Ltd. indicated it files annual reports under cover of Form 20-F.
Filing Stats: 196 words · 1 min read · ~1 pages · Grade level 12.3 · Accepted 2025-12-03 12:02:25
Filing Documents
- zk2534088.htm (6-K) — 11KB
- exhibit_99-1.htm (EX-99.1) — 16KB
- image0.jpg (GRAPHIC) — 135KB
- image1.jpg (GRAPHIC) — 112KB
- 0001178913-25-003999.txt ( ) — 368KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. SHL TELEMEDICINE LTD. By: /s/ Lior Haalman Lior Haalman Chief Financial Officer December 3, 2025 3